If you have ever lived with irritable bowel syndrome (IBS), you may have heard a frustrating message: “Your colonoscopy is clean and your bloodwork is normal, so nothing appears structurally wrong.” For decades, gastroenterology worked to explain why mild intestinal gas or normal digestive contractions can trigger severe abdominal pain. A 2026 randomized, sham-controlled clinical and neurobiological study published in the journal Gut (Weng et al., 2026; PMID: 41629148) investigated how brain circuits contribute to visceral hypersensitivity in diarrhea-predominant IBS (IBS-D). By applying clinic-delivered low-frequency repetitive transcranial magnetic stimulation (lf-rTMS) over the medial prefrontal cortex (mPFC) in 42 patients with IBS-D, and mapping neural pathways in a companion mouse model, researchers reported that dampening mPFC hyperactivity was followed by higher rectal sensory thresholds and lower IBS symptom scores compared with sham stimulation.
Watch: A Sham-Controlled Trial of Prefrontal Brain Stimulation for Visceral Pain in IBS-D
Prefer a rapid visual walkthrough? Watch our 69-second annotated scientific breakdown before reading the full peer-reviewed study analysis below.
- ▶️ 0:09 — The Ascending Visceral Pain Circuit: In IBS with diarrhea (IBS-D), visceral sensory signals interact with central pain networks…
- ▶️ 0:20 — Transcranial Magnetic Stimulation: In a 42-patient randomized trial in Gut (2026), clinicians delivered 2 weeks of low-frequency rTMS over the mPFC…
- ▶️ 0:31 — Preclinical Glutamatergic Circuit Mapping: Companion mouse experiments examined anterior-cingulate-to-mPFC glutamatergic neuron activity and NR2A expression…
- ▶️ 0:41 — Cortical Hyperactivity & fMRI: Resting-state fMRI after the 2-week course showed lower mPFC hyperactivity compared with sham…
- ▶️ 0:50 — High-Resolution Anorectal Manometry Evidence: Manometry showed higher rectal sensory thresholds (first sensation, desire to defecate, maximum tolerable volume), with symptom and threshold gains sustained at 8 weeks…
- ▶️ 0:59 — Clinical Context & Scope: How clinic-delivered neuromodulation differs from general brain-gut behavioral and lifestyle care…
Executive Summary: The Cortical Pain Hub of IBS-D
- The Rome IV Framework: Irritable bowel syndrome is classified as a Disorder of Gut-Brain Interaction (DGBI). Visceral hypersensitivity involves both peripheral gut signaling and central sensory processing within the brain1,2.
- The Weng et al. Study (Gut, 2026): Combining a randomized, sham-controlled clinical trial in 42 patients with IBS-D (`n=21` per group) and a companion mouse model, researchers reported that medial prefrontal cortex (mPFC) hyperactivity correlated with visceral pain severity, and that glutamatergic projections from the anterior cingulate cortex (ACC) to the mPFC drove visceral hypersensitivity in mice1.
- Clinic-Delivered Low-Frequency rTMS over the mPFC: Two weeks of clinic-delivered low-frequency repetitive transcranial magnetic stimulation (lf-rTMS) targeting the mPFC reduced mPFC activity on resting-state fMRI after the 2-week course. In companion mouse experiments, rTMS reduced c-Fos activity in mPFC glutamatergic neurons, accompanied by lower NR2A receptor subunit expression1.
- Manometric & Symptom Outcomes: High-resolution anorectal manometry (HARM) and validated symptom scales showed that active lf-rTMS was followed by higher rectal sensory thresholds (first sensation, desire to defecate, and maximum tolerable volume) and lower Visceral Sensitivity Index (VSI), IBS Symptom Severity Scale (IBS-SSS), and Bristol Stool Form Scale (BSFS) scores than sham, with symptom and sensory threshold improvements sustained at the 8-week follow-up. As the authors note, this was a single-centre study with a modest sample size (`n=42`) that warrants validation in larger, multicentre trials1.
- Clinical vs. General Lifestyle Scope: Low-frequency rTMS is a clinic-administered medical procedure. Weng et al. (2026) did not test diet, breathing, or supplement interventions; clinical guidelines such as the 2021 American College of Gastroenterology (ACG) IBS guideline suggest gut-directed psychotherapy for global IBS symptoms alongside individualized medical care1,3.
1. Visceral Hypersensitivity: Why Clean Scopes Do Not Mean Imaginary Pain
Under healthy baseline physiology, the gastrointestinal tract is continuously in motion. Chyme moves through the small intestine, microbial fermentation generates carbon dioxide and hydrogen, and peristaltic motor contractions sweep down the colon. In a healthy nervous system, low-threshold mechanoreceptors on sensory nerve endings register this mechanical distension, transmitting silent electrical impulses up the spinal cord to the brainstem. The brain employs an active neurological filtering mechanism known as visceral sensory gating, ensuring these basal signals never reach conscious cortical awareness.
In individuals suffering from IBS, however, this sensory gating system breaks down catastrophically. The threshold for pain sensation plummets, a state termed visceral hypersensitivity. Normal physiological events—such as a small bubble of intestinal gas or a standard postprandial peristaltic wave—are perceived as agonizing cramps, intense pressure, and urgent bowel distress2,4.
For generations, medicine viewed this dysfunction primarily through a peripheral lens: clinicians looked for bleeding ulcers, macroscopic mucosal erosions, or pathogenic bacterial infections. When routine colonoscopies returned normal, patients were frequently dismissed. Today, neuroimaging studies using functional MRI (fMRI) show that visceral pain involves bi-directional signaling across peripheral and central pain networks3,5.

As illustrated conceptually in Figure 1, sensory signals from the gut wall travel along spinal afferents through the thalamus and project into interconnected cortical regions: the insular cortex (interoceptive awareness), the anterior cingulate cortex (ACC) (affective pain processing), and the medial prefrontal cortex (mPFC) (cognitive appraisal and pain modulation)4,5.
In patients with IBS-D, Weng et al. (2026) observed that mPFC hyperactivity correlated with visceral pain severity, and companion mouse experiments identified hyperactive glutamatergic projections from the ACC to the mPFC as a central driver of visceral hypersensitivity1.
Unlock the GutBrain Clinical Research Vault
You are reading an evidence-based clinical investigation. Unlock the complete protocol, technical diagrams, and clinical action steps below:
Full access has been granted in your browser. Scroll down to review the complete protocol and technical figures.
Looking for structured protocol blueprints? Explore The GutBrain Master System v1 ($20).
Instant access. Zero spam. Unsubscribe in 1-click anytime.
2. The Weng et al. Investigation: Pinpointing the Cortical Target
If medial prefrontal cortex hyperactivity correlates with visceral pain in IBS-D, does dampening this brain region reduce visceral hypersensitivity? This question was investigated by Dr. Rui-Xia Weng, Dr. Rui Li, and colleagues in their study published in Gut in 2026 (PMID: 41629148)1.
To evaluate this clinically, the investigators conducted a randomized, sham-controlled clinical trial in 42 patients with diarrhea-predominant IBS (IBS-D). Participants were randomly assigned to two parallel arms (`n = 21` per group) across a 2-week course:
- Active Low-Frequency rTMS (n = 21): Patients received clinic-delivered low-frequency repetitive transcranial magnetic stimulation (lf-rTMS) targeted over the medial prefrontal cortex (mPFC) across two consecutive weeks1.
- Sham rTMS Control (n = 21): Control participants underwent a matching sham rTMS protocol over the same two-week schedule1.
High-Resolution Anorectal Manometry (HARM), fMRI & Clinical Outcomes
Alongside validated symptom questionnaires, the researchers evaluated rectal visceral sensitivity using High-Resolution Anorectal Manometry (HARM) with graded balloon distension to measure sensory thresholds for first sensation, desire to defecate, and maximum tolerable volume, and performed resting-state functional MRI (fMRI) before and after the 2-week intervention1.
| Clinical & Physiological Endpoint | Measurement Modality | 2-Week Post-Treatment Finding (Active lf-rTMS vs. Sham) | 8-Week Follow-Up Status (Figure 7) |
|---|---|---|---|
| IBS Symptom Severity Scale (IBS-SSS) | Validated clinical symptom & pain scale | Significantly lower total & abdominal pain intensity/frequency scores vs. sham | Symptom score improvements sustained at 8 weeks |
| Visceral Sensitivity Index (VSI) | Gastrointestinal-specific anxiety & sensitivity scale | Significantly lower VSI scores vs. sham | Sustained lower VSI scores at 8 weeks |
| Bristol Stool Form Scale (BSFS) | Stool consistency score | Improved stool consistency vs. sham | Sustained BSFS improvement at 8 weeks |
| Rectal Sensory Thresholds | High-resolution anorectal manometry (first sensation, desire to defecate, maximum tolerable volume) | Higher sensory volume thresholds across all three parameters vs. sham | Threshold improvements sustained at 8 weeks |
| Medial Prefrontal Cortex (mPFC) Activity | Resting-state functional MRI (fMRI; Figure 6F–G) | Reduced mPFC hyperactivity after the 2-week course vs. sham | Assessed at 2-week post-treatment endpoint |
Methodological Provenance & Study Limitations: Clinical endpoints, rectal sensory threshold categories, resting-state fMRI findings (Figure 6F–G), and 8-week follow-up assessments (Figure 7) are summarized from Weng et al. (Gut, 2026; PMID: 41629148; PMC13479640; DOI: 10.1136/gutjnl-2025-337612). As the authors explicitly state, this was a single-centre study with a relatively modest sample size (42 patients) and an 8-week follow-up window, and therefore warrants validation in larger, multicentre randomized controlled trials.
After the 2-week course, patients receiving active lf-rTMS demonstrated higher rectal sensory thresholds for first sensation, desire to defecate, and maximum tolerable volume on anorectal manometry, lower Visceral Sensitivity Index (VSI) and IBS-SSS scores, improved Bristol Stool Form Scale (BSFS) scores, and reduced mPFC hyperactivity on resting-state fMRI compared with sham stimulation1.
At the 8-week post-treatment follow-up (Figure 7), improvements in IBS-SSS pain intensity and frequency, VSI, BSFS stool consistency, and the three rectal sensory thresholds remained sustained compared with sham1.
3. Preclinical Circuit Mapping: Anterior Cingulate-to-mPFC Glutamatergic Signaling in Mice
To investigate the cellular and circuit mechanisms underlying cortical pain amplification, Weng and colleagues conducted parallel experiments in a neonatal maternal deprivation (NMD) mouse model of visceral hypersensitivity using fiber photometry, optogenetics, chemogenetics, and patch-clamp recordings1.

In the companion NMD mouse experiments (illustrated conceptually in Figure 2), the authors reported three key preclinical findings:
- Anterior Cingulate-to-mPFC Glutamatergic Input: Visceral hypersensitivity in NMD mice was driven by heightened activity in glutamatergic neurons in the medial prefrontal cortex (mPFC) receiving excitatory projections from the anterior cingulate cortex (ACC)1.
- NR2A Subunit Expression: Visceral pain sensitization in the mouse model was associated with increased expression of the NR2A subunit of NMDA receptors in the mPFC1.
- Attenuation by Low-Frequency rTMS in Mice: Applying 1 Hz low-frequency rTMS in NMD mice reduced c-Fos expression and excitability in mPFC glutamatergic neurons, accompanied by a reduction in NR2A expression and lower visceromotor pain responses to colorectal distension1.
4. Bi-Directional Brain-Gut Context in IBS Care
In clinical practice, Disorders of Gut-Brain Interaction such as IBS-D involve both peripheral digestive factors and central sensory processing:
- Peripheral Luminal & Mucosal Factors: Dietary triggers, bile acid malabsorption, motility shifts, and mucosal immune signaling can stimulate gut sensory nerves2,3.
- Central Sensory Processing: Neuroimaging studies show that prefrontal, insular, and cingulate networks modulate how visceral signals are perceived1,4,5.

5. Putting the Research in Context: Clinical Care vs. General Lifestyle Habits
Important Scope Note: Low-frequency rTMS over the mPFC is a specialized, clinic-delivered medical neuromodulation procedure investigated in a 42-patient single-centre trial. Weng et al. (2026) did not test any breathing exercise, fasting schedule, diet, or nutritional supplement1. The items below summarize established clinical guideline options and general educational lifestyle context to discuss with your gastroenterologist:
Guideline-Supported Brain-Gut Care & Autonomic Pacing
- Gut-Directed Psychotherapy (ACG Clinical Guideline): For patients seeking non-pharmacological central brain-gut support, the 2021 American College of Gastroenterology (ACG) Clinical Guideline for the Management of IBS suggests gut-directed psychotherapy for treating global IBS symptoms (Lacy et al., Am J Gastroenterol 2021; PMID: 33315591)6.
- General Stress-Reduction & Paced Breathing Habits: While not tested in Weng et al., slow diaphragmatic breathing and relaxation routines are commonly used as general stress-management habits to support parasympathetic tone3.
General Dietary & Digestive Routine Context
- Clinician-Guided Soluble Fiber & Meal Pacing: The 2021 ACG clinical guideline recommends soluble fiber (such as psyllium) over insoluble fiber to treat global IBS symptoms, alongside clinician-supervised dietary evaluation6.
- Balanced Nutrition & Microbiome Substrates: Adequate dietary protein and fermentable prebiotic substrates (as tolerated) support general intestinal barrier and microbiome physiology3. Always consult a qualified healthcare professional or registered dietitian to tailor nutrition to your specific IBS subtype.
Explore Educational Gut-Brain Guides & Resources
Understanding how central and peripheral circuits interact in IBS helps patients have more informed conversations with their gastroenterology care team. Explore our educational reference guides for structured lifestyle and nutrition summaries:
- The GutBrain Master System v1 ($20): An educational nutrition and daily routine reference guide covering meal spacing, dietary fiber selection, and microbiome fundamentals.
- The Vagal Motility & SIBO Educational Guide ($4): A plain-language educational overview of digestive motility physiology and questions to discuss with your clinician.
6. Peer-Reviewed References & Primary Literature Ledger
- Weng RX, Lin W, Sun Q, Ma CT, Zhang FC, Jia SM, Hu SF, Li YC, Zhang CH, Yu YJ, Zhao WM, Xu GY, Li R. Low-frequency repetitive transcranial magnetic stimulation attenuates visceral pain in IBS with diarrhoea via inhibition of the medial prefrontal cortex. Gut. 2026;75(2):gutjnl-2025-337612. DOI: 10.1136/gutjnl-2025-337612. PMID: 41629148.
- Drossman DA. Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features and Rome IV. Gastroenterology. 2016;150(6):1257–1261. DOI: 10.1053/j.gastro.2016.02.032. PMID: 27144617.
- Mayer EA, Labus JS, Tillisch K, Cole SW, Baldi P. Towards a systems view of IBS. Nature Reviews Gastroenterology & Hepatology. 2015;12(10):592–605. DOI: 10.1038/nrgastro.2015.121. PMID: 26303675.
- Van Oudenhove L, Vandenberghe J, Dupont P, Geeraerts B, Vos R, Bormans G, Van Laere K, Fischler B, Demyttenaere K, Janssens J, Tack J. Central nervous system processing of visceral pain in irritable bowel syndrome: a meta-analysis of neuroimaging studies. Gastroenterology. 2014;147(4):894–906. DOI: 10.1053/j.gastro.2014.07.019. PMID: 25042838.
- Tillisch K, Mayer EA, Labus JS. Quantitative meta-analysis identifies a core network of brain regions activated by visceral pain in functional gastrointestinal disorders. Neuroimage. 2011;55(4):1753–1762. DOI: 10.1016/j.neuroimage.2011.01.074. PMID: 21300164.
- Lacy BE, Pimentel M, Brenner DM, Chey WD, Keefer LA, Long MD, Moshiree B. ACG Clinical Guideline: Management of Irritable Bowel Syndrome. American Journal of Gastroenterology. 2021;116(1):17–44. DOI: 10.14309/ajg.0000000000001036. PMID: 33315591.
Medical Disclaimer: The educational content provided in this article is for general informational and scientific educational purposes only. It is not intended to provide medical advice, clinical diagnosis, or medical treatment protocols. Transcranial magnetic stimulation is a specialized clinical medical procedure studied in a single-centre research trial. Dietary adjustments, breathing practices, and lifestyle changes should always be reviewed with a qualified, licensed healthcare professional prior to implementation, especially for individuals managing medical diagnoses or taking prescription medications.